cognitive cybersecurity intelligence

News and Analysis

FDA Approves Botox Competitor That Lasts Longer

FRIDAY, Sept. 9, 2022 (HealthDay News) — People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades.
Daxxify, made by Revance Therapeutics Inc. in Nashville, Tenn.,…

Source: www.webmd.com – Read more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

Claude Code Source Leaked via npm Packaging Error, Anthropic Confirms

Anthropic on Tuesday confirmed that internal code for its popular artificial intelligence (AI) coding assistant, Claude Code, had been inadvertently released due to a human

TrueConf Vulnerability Under Active Exploitation in Southeast Asia Government Attacks

Check Point Research has discovered a critical zero-day vulnerability in the TrueConf video conferencing client. Tracked as CVE-2026-3502 with a CVSS score of 7.8, this

An analysis of CrystalX commercial RAT with prankware features – Securelist

An analysis of CrystalX commercial RAT with prankware features Securelist

Mimecast makes enterprise email security deployable in minutes

Most organizations running Microsoft 365 rely on native email controls as their primary line of defense. According to Mimecast research, 38% of organizations depend exclusively

News and Analysis

FDA Approves Botox Competitor That Lasts Longer

Subscribe to newsletter

More Posts

Claude Code Source Leaked via npm Packaging Error, Anthropic Confirms

TrueConf Vulnerability Under Active Exploitation in Southeast Asia Government Attacks

An analysis of CrystalX commercial RAT with prankware features – Securelist

Mimecast makes enterprise email security deployable in minutes

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company